Moderna's Melanoma Vaccine Given 'Breakthrough Therapy' Status by FDA
Feb 27, 2023•3 min
Episode description
Moderna's Melanoma Vaccine has been granted "breakthrough therapy" status by the US Food and Drug Administration (FDA), paving the way for a rapid approval process in just six months.
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
For the best experience, listen in Metacast app for iOS or Android
